Skip to content

Clinical trials

Phase 1/2 Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Country / region: United States Clear all

218 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20027
200313
20043
20059
20068
20079
200812
20095
20106
20114
20127
201312
201413
201512
201610
201712
20186
20196
20205
20218
20228
20238
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Terminated51
Recruiting20
Active, not recruiting14
Unknown status9
Withdrawn9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center17
National Cancer Institute (NCI)11
Memorial Sloan Kettering Cancer Center10
Incyte Corporation6
Northwestern University6
Fred Hutchinson Cancer Center5
Masonic Cancer Center, University of Minnesota4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
UNC Lineberger Comprehensive Cancer Center4
Abramson Cancer Center at Penn Medicine3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma218
Lymphoma, Non-Hodgkin74
Leukemia73
Lymphoma, Large B-Cell, Diffuse59
Lymphoma, Follicular55
Lymphoma, Mantle-Cell52
Leukemia, Lymphocytic, Chronic, B-Cell51
Hodgkin Disease44
Lymphoma, B-Cell, Marginal Zone37
Burkitt Lymphoma36

Trials

Showing 1 to 25 of 218. Each trial links to its page on Pharma Observatory.

118 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.